Table 4.
Mortality associated with infection site and pathogen
| Overall | TPE | No TPE | p | |
|---|---|---|---|---|
| Site of infection | ||||
| Pneumonia | 26/40 (65%) | 11/23 (47.8%) | 15/17 (88.2%) | 0.017 |
| GU | 2/14 (14.3%) | 0/6 (0%) | 2/8 (25%) | |
| GI/biliary | 6/12 (50%) | 2/6 (33.3%) | 4/6 (66.7%) | |
| Skin/soft tissue | 1/5 (20%) | 1/1 (100%) | 0/4 (0%) | |
| Endocarditis | 2/4 (50%) | 1/3 (33.3%) | 1/1 (100%) | |
| Primary bacteremia | 5/5 (100%) | 1/1 (100%) | 4/4 (100%) | |
| Organism cultured | ||||
| MRSA | 2/5 (40%) | 1/3 (33.3%) | 1/2 (50%) | |
| Streptococcus | 3/5 (60%) | 1/2 (50%) | 2/3 (66.7%) | |
| E. coli | 6/11 (54.5%) | 2/5 (40%) | 4/6 (66.7%) | |
| Pseudomonas | 2/2 (100%) | 1/1 (100%) | 1/1 (100%) | |
| Enterococcus | 1/2 (50%) | 0/1 (0%) | 1/1 (100%) | |
| Enterobacter | 3/8 (37.5%) | 2/3 (66.7%) | 1/5 (20%) | |
| Klebsiella | 2/6 (33.3%) | 0/4 (0%) | 2/2 (100%) | |
| Influenza | 2/3 (66.7%) | 0/1 (0%) | 2/2 (100%) | |
| Serratia | 1/1 (100%) | 1/1 (100%) | n/a | |
| C. difficile | 1/2 (50%) | n/a | 1/2 (50%) | |
| Salmonella | 0/1 (0%) | n/a | 0/1 (0%) | |
| Culture negative | 3/14 (21.4%) | 1/10 (10%) | 2/4 (50%) | |
| Polymicrobial | 16/20 (80%) | 7/9 (77.8%) | 9/11 (81.8%) | |
*Pathogens in polymicrobial infections are not specified in the numbers above